Ex vivo reprogramming of human hematopoietic stem cells is accompanied by increased transcripts of genes regulating metabolic integrity
Experimental Hematology · 2023
DOI: 10.1016/j.exphem.2023.03.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Hematology, 2023. Verfasst von Luena Papa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, New York State Stem Cell Science.
Abstract (Originalsprache)
The regenerative potential of human hematopoietic stem cells (HSCs) is functionally defined by their ability to provide life-long blood cell production and to repopulate myeloablated allogeneic transplant recipients. The expansion of HSC numbers is dependent not only on HSC divisions but also on a coordinated adaptation of HSCs to metabolic stress. These variables are especially critical during the ex vivo culture of HSCs with cytokine combinations, which frequently results in HSC exhaustion. We have previously reported that human CD34+ hematopoietic stem and progenitor cells (HSPCs) can be efficiently reprogrammed ex vivo and that the number of phenotypic HSCs with long-term repopulation capacity is expanded in the presence of a combination of cytokines and an epigenetic modifier. Here, we present evidence that ex vivo HSC reprogramming and maintenance is accompanied by increased transcripts of genes regulating metabolic integrity, including SIRT1 and SIRT3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
- Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
- Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
- Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electr…
- Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY; Depart…
Förderung
- NCI NIH HHS
- New York State Stem Cell Science
Zitieren
APA
Papa, L., Martin, T. C., Djedaini, M., Zangui, M., Ozbek, U., Parsons, R., Hoffman, R., & Schaniel, C. (2023). Ex vivo reprogramming of human hematopoietic stem cells is accompanied by increased transcripts of genes regulating metabolic integrity. Experimental Hematology. https://doi.org/10.1016/j.exphem.2023.03.006
Vancouver
Papa L, Martin TC, Djedaini M, Zangui M, Ozbek U, Parsons R, et al. Ex vivo reprogramming of human hematopoietic stem cells is accompanied by increased transcripts of genes regulating metabolic integrity. Experimental Hematology. 2023. doi:10.1016/j.exphem.2023.03.006
BibTeX
@article{Papa2023,
author = {Papa, Luena and Martin, Tiphaine C and Djedaini, Mansour and Zangui, Mahtab and Ozbek, Umut and Parsons, Ramon and Hoffman, Ronald and Schaniel, Christoph},
title = {Ex vivo reprogramming of human hematopoietic stem cells is accompanied by increased transcripts of genes regulating metabolic integrity},
journal = {Experimental Hematology},
year = {2023},
doi = {10.1016/j.exphem.2023.03.006}
}
EUVIMED